Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach

The present study aims to design and optimize the lornoxicam dispersible tablet (LXDT) formulation using the Quality by design (QbD) approach. A randomized Box–Behnken experimental design was used to characterize the effect of the critical factors, such as filler (MCC/Mannitol) ratio, mixing time, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Almotairi, Nawaf, Mahrous, Gamal M., Al-suwayeh, Saleh, Kazi, Mohsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785951/
https://www.ncbi.nlm.nih.gov/pubmed/36558914
http://dx.doi.org/10.3390/ph15121463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785951/
https://www.ncbi.nlm.nih.gov/pubmed/36558914
http://dx.doi.org/10.3390/ph15121463

Ejemplares similares